Odyssey Health extends promissory note maturity

Odyssey Health, Inc. reported that on October 9, 2025 it entered into Amendment No. 6 to its promissory note issued on December 13, 2022 with Mast Hill Fund, L.P.

Rhea-AI Filing Summary

Odyssey Health, Inc. reported that on October 9, 2025 it entered into Amendment No. 6 to its promissory note issued on December 13, 2022 with Mast Hill Fund, L.P.

Under this amendment, the maturity date of the promissory note is extended to April 30, 2026, giving the company more time before the debt comes due. The amendment also deletes Section 4.16 titled “Amortization Payments” in its entirety, while all other terms and conditions of the note remain the same.

Insights

Credit & capital structure analyst

Debt maturity is pushed to April 2026, with amortization removed while other terms stay intact.

The company has amended its promissory note with Mast Hill Fund, L.P., moving the maturity date to April 30, 2026. Extending a maturity generally reduces near-term repayment pressure by giving the borrower more time before principal is due.

The amendment also deletes the “Amortization Payments” section, which suggests previously scheduled installment payments are no longer required under that clause. With all other terms unchanged, the economic impact will depend on the note’s original size, interest rate, and covenants, which are not detailed here.

Investors may focus on how this extended timeline to April 30, 2026 affects Odyssey Health’s cash needs and funding plans, as future disclosures could clarify whether this change improves liquidity or simply defers obligations.

8-K Event Classification

3 items: 1.01, 2.03, 9.01

3 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial

The company incurred a new significant debt or off-balance-sheet obligation.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Odyssey Health, Inc. (ODYY) announce in this 8-K?

Odyssey Health, Inc. disclosed that it entered into Amendment No. 6 to a promissory note with Mast Hill Fund, L.P., extending the maturity date and removing the amortization payments section while leaving all other terms unchanged.

Which promissory note did Odyssey Health (ODYY) amend?

The amendment applies to the promissory note originally issued on December 13, 2022 between Odyssey Health, Inc. and Mast Hill Fund, L.P.

What is the new maturity date of Odyssey Health’s note with Mast Hill Fund?

The maturity date of the promissory note has been extended to April 30, 2026 under Amendment No. 6.

What change was made to amortization payments for Odyssey Health’s promissory note?

Section 4.16 titled “Amortization Payments” was deleted in its entirety from the promissory note, meaning that provision no longer applies, while other terms remain the same.

Did Odyssey Health (ODYY) change any other terms of the Mast Hill promissory note?

No. Aside from extending the maturity date to April 30, 2026 and deleting the amortization payments section, all other terms and conditions of the promissory note remain the same according to the disclosure.

Where can investors find the full text of Amendment No. 6 for Odyssey Health?

The full text of Amendment No. 6 to the promissory note with Mast Hill, L.P. is filed as Exhibit 10.1 to this report and incorporated by reference.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/10/2025 - 05:10 PM Learn about SEC filing dates

false 0001626644 0001626644 2025-10-09 2025-10-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: October 9, 2025

(Date of earliest event reported)

ODYSSEY HEALTH, INC.

(Exact name of registrant as specified in its charter)

Nevada	000-56196	47-1022125
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)

2300 West Sahara Avenue, Suite 800 - #4012, Las Vegas, NV	89102
(Address of principal executive offices)	(Zip Code)

(702) 780-6559

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(g) of the Act:

Title of each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock ($0.001 par value)	ODYY	OTCQB

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On October 9, 2025, Odyssey Health, Inc. entered into Amendment No. 6 to the Promissory Note issued on December 13, 2022, with Mast Hill Fund, L.P. Pursuant to Amendment No. 6, the parties have agreed to extend the maturity date of the note to April 30, 2026, and Section 4.16 “Amortization Payments” was deleted in its entirety. All other terms and conditions remain the same.

Amendment No. 6 to the Promissory Note is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth above under Item 1.01 is hereby incorporated by reference into this Item 2.03.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Number	Exhibit
10.1	Amendment No. 6 to the Promissory Note with Mast Hill, L.P.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Odyssey Health, Inc.
Date: October 10, 2025	By:	/s/ Joseph Michael Redmond
		Joseph Michael Redmond Chief Executive Officer

2